T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Cenovus Energy
CVE
$56.2B
| $299K | ﹤0.01% |
29,800
| – | – |
|
2352
Northrim BanCorp
NRIM
$604M
| $299K | ﹤0.01% |
28,820
+160
| +0.6% | +$1.69K |
|
2353
Western New England Bancorp
WNEB
$282M
| $296K | ﹤0.01% |
27,413
-341
| -1% | -$3.69K |
|
|
PBIP
2354
DELISTED
Prudential Bancorp, Inc.
PBIP
| $296K | ﹤0.01% |
17,088
-536
| -3% | -$9.95K |
|
2355
Greenlight Captial
GLRE
$511M
| $295K | ﹤0.01% |
23,750
-723
| -3% | -$9.55K |
|
|
CYBE
2356
DELISTED
Cyberoptics Corp
CYBE
| $295K | ﹤0.01% |
14,600
| – | – |
|
|
CNBKA
2357
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $295K | ﹤0.01% |
4,084
+17
| +0.4% | +$1.27K |
|
|
SEND
2358
DELISTED
SendGrid, Inc.
SEND
| $295K | ﹤0.01% |
+8,017
| New | +$253K |
|
|
XCRA
2359
DELISTED
Xcerra Corporation
XCRA
| $294K | ﹤0.01% |
20,609
+100
| +0.5% | +$1.42K |
|
2360
8x8 Inc
EGHT
$290M
| $290K | ﹤0.01% |
13,645
+952
| +8% | +$20.8K |
|
2361
Medpace
MEDP
$16.4B
| $290K | ﹤0.01% |
+4,846
| New | +$265K |
|
|
AD
2362
Array Digital Infrastructure
AD
$3.09B
| $288K | ﹤0.01% |
6,421
+62
| +1% | +$2.5K |
|
2363
Malibu Boats
MBUU
$577M
| $286K | ﹤0.01% |
5,235
+122
| +2% | +$5.42K |
|
2364
Artisan Partners
APAM
$2.99B
| $284K | ﹤0.01% |
8,775
| – | – |
|
2365
Unitil
UTL
$994M
| $284K | ﹤0.01% |
5,571
+87
| +2% | +$4.44K |
|
|
HPR
2366
DELISTED
HighPoint Resources Corporation
HPR
| $284K | ﹤0.01% |
1,164
-433
| -27% | -$124K |
|
2367
AerCap
AER
$23.5B
| $282K | ﹤0.01% |
4,907
+500
| +11% | +$28.2K |
|
|
FLXN
2368
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $282K | ﹤0.01% |
15,087
+3,703
| +33% | +$85.1K |
|
2369
AMES National
ATLO
$283M
| $281K | ﹤0.01% |
10,302
+52
| +0.5% | +$1.56K |
|
2370
NVE Corp
NVEC
$569M
| $281K | ﹤0.01% |
2,656
-71
| -3% | -$8.18K |
|
|
IVC
2371
DELISTED
Invacare Corporation
IVC
| $278K | ﹤0.01% |
19,080
-302
| -2% | -$5K |
|
|
AXE
2372
DELISTED
Anixter International Inc
AXE
| $278K | ﹤0.01% |
3,948
+175
| +5% | +$12.3K |
|
|
KERX
2373
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $278K | ﹤0.01% |
81,773
+28,781
| +54% | +$104K |
|
2374
FreightCar America
RAIL
$243M
| $277K | ﹤0.01% |
17,254
| – | – |
|
|
PFBI
2375
DELISTED
Premier Financial Bancorp
PFBI
| $277K | ﹤0.01% |
14,976
-129
| -0.9% | -$2.49K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.